UK Kidney Week 2026 - Revised Dates
UK Kidney Week 2026 will now take place from 10-12 March 2026 at the Harrogate Convention Centre. This shift from our usual June timing avoids a clash with the European Renal Association (ERA) Congress scheduled for 3-6 June 2026 in Glasgow. Ahead of this, the UKKA explored the possibility of a...
Read more
New training: Diabetes in Dialysis
A significant proportion of people receiving dialysis also live with diabetes, creating complex challenges for both care teams and individuals. The UK Kidney Association has launched a new online training module, Diabetes in Dialysis, based on the 2023 JBDS-IP/UKKA Management of Adults with Diabetes...
Read more
Career-defining awards & lectures: Nominations now open
Nominations are now open for some of the most significant awards and lectures in the kidney community. These honours represent career milestones - marking individuals out as leaders among peers, strengthening professional standing, and providing a platform to influence the direction of kidney care...
Read more
New Rare Kidney Conditions Patient Information Committee – expressions of interest open
Expressions of interest are invited for the role of Medical Chair as well as medical and multi-professional members of a new Rare Kidney Conditions Patient Information Committee. This new committee will support the work of the UK Kidney Association’s Patient Information Committee, working in...
Read more
Kidney leaders join call for stronger action on prevention
The UK Kidney Association has joined MPs, patient organisations, and health professionals in signing an open letter urging government and NHS leaders to strengthen the focus on CKD prevention within the Ten-Year Plan. The letter, led by Dr Simon Opher MP (Chair, All Party Parliamentary Group on...
Read more
Use of generic dapagliflozin in CKD: UKKA statement
The UK Kidney Association (UKKA) endorses the use of generic dapagliflozin for patients with Chronic Kidney Disease (CKD), consistent with NICE guidelines. There is robust evidence that SGLT2 inhibitors have a class effect and have demonstrated clear efficacy, including reducing the risk of end...
Read more
Dr Yusuf Jinadu appointed Medical Co-Chair of the UKKA International Committee
The UK Kidney Association is delighted to announce that Dr Yusuf Olanrewaju Jinadu has been appointed as the new Medical Co-Chair of the International Committee. Dr Jinadu succeeds Professor Sunil Bhandari, whose leadership has guided the Committee’s success in recent years. Reflecting on his...
Read more
Prepare for Nephrology Exams
The European Specialty Examination in Nephrology (ESENeph), delivered in partnership with the UK Kidney Association, is held every nine months and tests knowledge across the breadth of the specialty. The UKKA’s ESENeph Study Day and Advanced Nephrology Course provide targeted preparation to help you...
Read more
Applications open for the UKKA Experiential Leadership Programme 2026
We have opened applications for our 2026 Experiential Leadership Programme – a 12-month, hands-on development opportunity for early- to mid-career kidney professionals from all disciplines. The programme is designed to build the next generation of leaders in kidney care, offering participants the...
Read more
National CKD Leads Appointed
The UK Kidney Association is delighted to announce the appointment of Dr Kristin Veighey and Dr Rupert Major as national clinical leads for the Integrated CKD project - an ambitious UK-wide initiative to improve the early identification and management of chronic kidney disease (CKD). Together, they...
Read more